Area(s) of expertise: Senior VP, Quintiles Outcome
Summary of expertise:
Dr. Nancy Dreyer is Chief of Scientific Affairs and Senior Vice President at Quintiles Outcome. She leads a team of researchers who design, conduct, and interpret observational research on comparative effectiveness, safety and quality improvement programs.
In 2009, Dr. Dreyer joined the Steering Committee for the European Medicines Agency’s PROTECT Project for the Innovative Medicines Initiative. In 2007, she was recognized by the trade journal, Pharmavoice as one of the 100 most inspiring people in the pharmaceutical and life sciences industry.
Dr. Dreyer has more than 25 years of experience in epidemiologic research. She trained at the University of North Carolina in Chapel Hill, earning a masters degree and doctorate in Epidemiology. Dr. Dreyer was CEO of Epidemiology Resources, Inc., a job she held from the company’s inception through its acquisition 20 years later by UnitedHealth Group. In that role, she launched and published the peer‑reviewed journal, Epidemiology, for its first ten years, and led the New England Epidemiology Institute, a summer program that trained more than 5000 scientists through collaboration with international medical schools and schools of public health. Dr. Dreyer is a Fellow and Board Member of the International Society of Pharmacoepidemiology.
- Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, eds. Developing a Protocol for Observational Comparative Effectiveness Research. A User’s Guide. AHRQ Publication No. 12(13)-EHC099. Rockville, MD: Agency for Healthcare Research and Quality. January 2013.
- Velentgas P, Dreyer NA, Wu AW. Outcome definition and measurement. In Velentgas P, Dreyer, NA, Nourjah P et al., eds. Developing a Protocol for Observational Comparative Effectiveness Research. A User’s Guide. Rockville, MD: Agency for Healthcare Research and Quality. 2013: Chapter 6, pp. 71-92.
- Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User’s Guide. Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. dba Outcome] under Contract No. HHSA29020050035I TO1. AHRQ Publication No. 07-EHC001-1. Rockville, MD: Agency for Healthcare Research and Quality. 2nd Edition, September, 2010. Also available in Korean through the Korean National Evidence-based Healthcare Collaborating Agency, published December 31, 2010. and in Chinese, published in December, 2012.
- Dreyer NA, Velentgas P. Registries. In Pharmacoepidemiology, Strom B, Kimmel S, Hennessy S, Eds. Fifth edition, John Wiley & Sons Ltd., 2012.
- Berger ML, Dreyer N, Anderson F, Towse A, Sedrakyan A, Normand, SL. Prospective observational studies to assess comparative effectiveness: ISPOR good research practices task force report. Value in Health 2012;15(2):217-30.
- Gliklich R, Glennie J, Mattox PW, Graff JS, Garner S, Marrone CM, Shaya FT, Hansen J, Lewin J, Blackburn S, Berger M, Dreyer NA. Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force. Drug Information Journal 2012;26:185-191.
- Oner AF, Dogan N, Gasimov V, Adisasmito W, Coker R, Chan PKS, Lee N, Tsang O, Hanshaoworakul W, Zaman M, Bamgboye E, Swenson A, Toovey S and Dreyer NA: H5N1 Avian Influenza in Children. Clinical Infectious Disease 2012; 55:26-32.
- Gliklich RE, Leavy MB, Velentgas P, Dreyer NA, Tunis SR, Mohr P, Messner DA, Moloney RM, Karkare Su, Dubois RW, Graff JS: Incorporating Stakeholder Perspectives in Developing a Translation Table Framework for Comparative Effectiveness Research. Journal of Comparative Effectiveness Research 2012; 1(3):281-292.
- REGISTER Group (Campbell B, Patrick H, Dreyer NA, Grilli R, Franklin GM, Lee Robin SH, Maddern G, Tunis S, Lyratzopoulos). International collaboration in the use of registries for new devices and procedures. . British Journal of Surgery 2012; 99: 744–745.
- Chan PKS, Lee N, Zaman M, Adisasmito W, Coker R, Hanshaoworakul W, Gasmiov V, Oner AF, Dogan N, Tsang O, Phommasack B, Touch S, Bangboye E, Swenson A, Toovey S, Dreyer N: Determinants of Antiviral Effectiveness in H5N1 Avian Influenza. Journal of Infectious Disease 2012; 206: 1359-66.
Dr. Dreyer earned a masters degree and doctorate in Epidemiology from the University of North Carolina in Chapel Hill
Areas of expertise:
- Demystifying epidemiology
- The value of bringing population science to clinical research
- Current and future uses of registries to evaluate patient outcomes
- Advancing good practice guidance on observational methods for effectiveness and safety
No comments have been made.